Extensively drug-resistant tuberculosis (XDR-TB)

A course of treatment for uncomplicated tuberculosis takes a minimum of six months. When patients are resistant to the two most powerful first-line antibiotics (isoniazid and rifampicin), they are considered to have multidrug-resistant TB (MDR-TB).

Extensively drug-resistant tuberculosis (XDR-TB) is identified when patients show resistance to the second-line drugs administered for MDR-TB. The treatment options for XDR-TB are very limited. Two new drugs – bedaquiline and delamanid – have recently become available to some patients who have no other treatment options left.

For more information, please see tuberculosis.

Press release
"Most countries lag behind in implementing the existing and new tools that are available to tackle...
Press release
Only 4,800 people with DR-TB in 2016 were treated with two newer and much more effective medicines...
Statement
TB has overtaken HIV as the deadliest infectious disease, killing 1.8 million worldwide last year.
Testimony
Swaziland has one of the highest rates of TB and multidrug-resistant TB (MDR-TB) worldwide and 80...
Press release
A pioneering clinical trial aiming to find a radically improved course of treatment for drug-...
A course of treatment for uncomplicated tuberculosis takes a minimum of six months. When patients...
Updates
The paediatric TB project in Dushanbe starts its first patient on a new treatment, and more about...
Gallery
South Africa has one of the highest burdens of Tuberculosis (TB) and (Drug Resistant) DR-TB in the...
Press release
“The lack of solid data and evidence on the safety and efficacy of the new TB drugs means that only...
Patient story
"I'm happy I got this treatment, because I couldn't even walk back then," she says, "but if I see...
Testimony
“These new drugs are really the last life-line for patients who have ran out of all other options”...
Gallery
MSF is one of the biggest non-governmental providers of tuberculosis (TB) treatment – including for...
Georgia
In 2016, over 150 patients in Georgia were receiving bedaquiline or delamanid as part of an...
Press release
MSF urges Indian Prime Minister not to cave to pressure from EU to accept trade deal that could...
Press release
“TB is curable, yet it is now the infectious disease that kills the most people in the world,” said...
Press release
"The price for delamanid needs to come down to an affordable level, and Otsuka should also register...

Pages